Annual CFI
$41.00 K
+$5000.00+13.89%
31 December 2023
Summary:
XTL Biopharmaceuticals annual cash flow from investing activities is currently $41.00 thousand, with the most recent change of +$5000.00 (+13.89%) on 31 December 2023. During the last 3 years, it has risen by +$9000.00 (+28.12%). XTLB annual CFI is now -99.74% below its all-time high of $15.49 million, reached on 31 December 2003.XTLB Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
N/A
31 March 2024
Summary:
XTL Biopharmaceuticals quarterly cash flow from investing activities is not available.XTLB Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
N/A
31 March 2024
Summary:
XTL Biopharmaceuticals TTM cash flow from investing activities is not available.XTLB TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XTLB Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +13.9% | - | - |
| 3 y3 years | +28.1% | - | - |
| 5 y5 years | -94.7% | - | - |
XTLB Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +412.5% | ||||
| 5 y | 5 years | -98.1% | +412.5% | ||||
| alltime | all time | -99.7% | +100.2% |
XTL Biopharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $41.00 K(+13.9%) | - | - |
| Dec 2022 | $36.00 K(+350.0%) | - | - |
| Dec 2021 | $8000.00(-75.0%) | - | - |
| Dec 2020 | $32.00 K(-98.5%) | - | - |
| Dec 2019 | $2.11 M(+171.3%) | - | - |
| Dec 2018 | $778.00 K(-131.2%) | - | - |
| Dec 2017 | -$2.50 M(+3680.3%) | - | - |
| Dec 2016 | -$66.00 K(-40.0%) | - | - |
| Dec 2015 | -$110.00 K(-107.3%) | - | - |
| Dec 2014 | $1.50 M(-55.1%) | $516.00 K(+210.8%) | $1.50 M(+3844.7%) |
| Sept 2014 | - | $166.00 K(-69.1%) | $38.00 K(-99.0%) |
| June 2014 | - | $538.00 K(+92.8%) | $3.65 M(+17.4%) |
| Mar 2014 | - | $279.00 K(-129.5%) | $3.11 M(-6.7%) |
| Dec 2013 | $3.34 M(-375.9%) | -$945.00 K(-125.0%) | $3.34 M(-6.1%) |
| Sept 2013 | - | $3.78 M(<-9900.0%) | $3.55 M(-5174.3%) |
| June 2013 | - | -$3000.00(-100.6%) | -$70.00 K(-95.9%) |
| Mar 2013 | - | $502.00 K(-168.9%) | -$1.69 M(+39.6%) |
| Dec 2012 | -$1.21 M | -$729.00 K(-555.6%) | -$1.21 M(-17.4%) |
| Sept 2012 | - | $160.00 K(-109.9%) | -$1.46 M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | - | -$1.62 M(-265.2%) | -$1.47 M(-200.8%) |
| Mar 2012 | - | $981.00 K(-199.8%) | $1.46 M(-206.5%) |
| Dec 2011 | -$1.37 M(+5616.7%) | -$983.00 K(-755.3%) | -$1.37 M(+252.7%) |
| Sept 2011 | - | $150.00 K(-88.6%) | -$389.00 K(-30.9%) |
| June 2011 | - | $1.31 M(-170.9%) | -$563.00 K(-70.1%) |
| Mar 2011 | - | -$1.85 M(+7616.7%) | -$1.88 M(+3320.0%) |
| Sept 2010 | - | -$24.00 K(+380.0%) | -$55.00 K(0.0%) |
| June 2010 | - | -$5000.00(-80.8%) | -$55.00 K(+10.0%) |
| Mar 2010 | - | -$26.00 K(<-9900.0%) | -$50.00 K(+108.3%) |
| Dec 2009 | -$24.00 K(-100.2%) | $0.00(-100.0%) | -$24.00 K(0.0%) |
| Sept 2009 | - | -$24.00 K(<-9900.0%) | -$24.00 K(<-9900.0%) |
| June 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2009 | - | $0.00 | $0.00 |
| Dec 2008 | $10.91 M(+2.6%) | - | - |
| Dec 2007 | $10.64 M(-151.1%) | - | - |
| Dec 2006 | -$20.83 M(-318.7%) | - | - |
| Dec 2005 | $9.53 M(+24.5%) | - | - |
| Dec 2004 | $7.65 M(-50.6%) | - | - |
| Dec 2003 | $15.49 M | - | - |
FAQ
- What is XTL Biopharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual CFI year-on-year change?
- What is the all time high quarterly CFI for XTL Biopharmaceuticals?
- What is the all time high TTM CFI for XTL Biopharmaceuticals?
What is XTL Biopharmaceuticals annual cash flow from investing activities?
The current annual CFI of XTLB is $41.00 K
What is the all time high annual CFI for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual cash flow from investing activities is $15.49 M
What is XTL Biopharmaceuticals annual CFI year-on-year change?
Over the past year, XTLB annual cash flow from investing activities has changed by +$5000.00 (+13.89%)
What is the all time high quarterly CFI for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly cash flow from investing activities is $3.78 M
What is the all time high TTM CFI for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high TTM cash flow from investing activities is $3.65 M